AI-washing – when AI hype becomes a litigation risk
Bryan Lowrance
Partner Corporate & Finance
+1 617 702 7746Boston
+1 212 918 3000New York
Prior to joining Hogan Lovells, Bryan practiced in the Boston office of another premier global law firm.
A leading medical technology company on multiple transactions.*
AbbVie in its acquisition of Capstan Therapeutics*
Eversource in the divestiture of its Aquarion water business*
A medical imaging company on its acquisition of an AI platform.*
MACOM Technology Solutions on multiple transactions.*
Becton, Dickinson and Company on multiple transactions.*
Max Finkelstein, Inc. on its sale to U.S. Autoforce.*
American Well on its acquisition of Conversa Health.*
Altimeter Growth Corp. on its US$40 billion stock-for-stock deSPAC combination with Grab Holdings Inc.*
ProSight Global, a specialty insurance company, on its sale to investment funds affiliated with TowerBrook Capital Partners.*
A special committee of the board of Akcea Therapeutics in connection with the sale of Akcea to Ionis Pharmaceuticals.*
Town Fair Tire on its sale to Mavis Tire Express Services.*
Radius Health on its acquisition by Gurnet Point Capital and Patient Square Capital.*
TravelCenters of America on its acquisition by BP.*
A large sovereign wealth fund on its investment in a major U.S. asset manager.*
A pharmaceutical company in responding to an activist investor.*
A pharmaceutical company in a proxy contest with an activist investor.*
CIRCOR in a proxy contest with an activist investor.*
Voya Prime Rate Trust in a proxy contest with an activist investor.*
Various registered funds in connection with activist investors.*
*Matter handled prior to joining Hogan Lovells.